img

Global Chondroprotective Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chondroprotective Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Chondroprotective Agent report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chondroprotective Agent market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Ambulatory Surgery Center are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chondroprotective Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


SANXIN
WanTuMing Biological
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek (Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow
Segment by Type
Sodium Hyaluronate
Glucosamine Sulfate
Chondroitin Sulfate

Segment by Application


Hospital
Ambulatory Surgery Center

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chondroprotective Agent market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chondroprotective Agent, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chondroprotective Agent industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chondroprotective Agent in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chondroprotective Agent introduction, etc. Chondroprotective Agent Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Chondroprotective Agent market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Chondroprotective Agent Market Overview
1.1 Chondroprotective Agent Product Overview
1.2 Chondroprotective Agent Market Segment by Type
1.2.1 Sodium Hyaluronate
1.2.2 Glucosamine Sulfate
1.2.3 Chondroitin Sulfate
1.3 Global Chondroprotective Agent Market Size by Type
1.3.1 Global Chondroprotective Agent Market Size Overview by Type (2018-2029)
1.3.2 Global Chondroprotective Agent Historic Market Size Review by Type (2018-2024)
1.3.3 Global Chondroprotective Agent Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chondroprotective Agent Sales Breakdown by Type (2018-2024)
1.4.2 Europe Chondroprotective Agent Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Chondroprotective Agent Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Chondroprotective Agent Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Chondroprotective Agent Sales Breakdown by Type (2018-2024)
2 Global Chondroprotective Agent Market Competition by Company
2.1 Global Top Players by Chondroprotective Agent Sales (2018-2024)
2.2 Global Top Players by Chondroprotective Agent Revenue (2018-2024)
2.3 Global Top Players by Chondroprotective Agent Price (2018-2024)
2.4 Global Top Manufacturers Chondroprotective Agent Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chondroprotective Agent Market Competitive Situation and Trends
2.5.1 Chondroprotective Agent Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Chondroprotective Agent Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chondroprotective Agent as of 2022)
2.7 Date of Key Manufacturers Enter into Chondroprotective Agent Market
2.8 Key Manufacturers Chondroprotective Agent Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chondroprotective Agent Status and Outlook by Region
3.1 Global Chondroprotective Agent Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Chondroprotective Agent Historic Market Size by Region
3.2.1 Global Chondroprotective Agent Sales in Volume by Region (2018-2024)
3.2.2 Global Chondroprotective Agent Sales in Value by Region (2018-2024)
3.2.3 Global Chondroprotective Agent Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Chondroprotective Agent Forecasted Market Size by Region
3.3.1 Global Chondroprotective Agent Sales in Volume by Region (2024-2029)
3.3.2 Global Chondroprotective Agent Sales in Value by Region (2024-2029)
3.3.3 Global Chondroprotective Agent Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Chondroprotective Agent by Application
4.1 Chondroprotective Agent Market Segment by Application
4.1.1 Hospital
4.1.2 Ambulatory Surgery Center
4.2 Global Chondroprotective Agent Market Size by Application
4.2.1 Global Chondroprotective Agent Market Size Overview by Application (2018-2029)
4.2.2 Global Chondroprotective Agent Historic Market Size Review by Application (2018-2024)
4.2.3 Global Chondroprotective Agent Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chondroprotective Agent Sales Breakdown by Application (2018-2024)
4.3.2 Europe Chondroprotective Agent Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Chondroprotective Agent Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Chondroprotective Agent Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Chondroprotective Agent Sales Breakdown by Application (2018-2024)
5 North America Chondroprotective Agent by Country
5.1 North America Chondroprotective Agent Historic Market Size by Country
5.1.1 North America Chondroprotective Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Chondroprotective Agent Sales in Volume by Country (2018-2024)
5.1.3 North America Chondroprotective Agent Sales in Value by Country (2018-2024)
5.2 North America Chondroprotective Agent Forecasted Market Size by Country
5.2.1 North America Chondroprotective Agent Sales in Volume by Country (2024-2029)
5.2.2 North America Chondroprotective Agent Sales in Value by Country (2024-2029)
6 Europe Chondroprotective Agent by Country
6.1 Europe Chondroprotective Agent Historic Market Size by Country
6.1.1 Europe Chondroprotective Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Chondroprotective Agent Sales in Volume by Country (2018-2024)
6.1.3 Europe Chondroprotective Agent Sales in Value by Country (2018-2024)
6.2 Europe Chondroprotective Agent Forecasted Market Size by Country
6.2.1 Europe Chondroprotective Agent Sales in Volume by Country (2024-2029)
6.2.2 Europe Chondroprotective Agent Sales in Value by Country (2024-2029)
7 Asia-Pacific Chondroprotective Agent by Region
7.1 Asia-Pacific Chondroprotective Agent Historic Market Size by Region
7.1.1 Asia-Pacific Chondroprotective Agent Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Chondroprotective Agent Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Chondroprotective Agent Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Chondroprotective Agent Forecasted Market Size by Region
7.2.1 Asia-Pacific Chondroprotective Agent Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Chondroprotective Agent Sales in Value by Region (2024-2029)
8 Latin America Chondroprotective Agent by Country
8.1 Latin America Chondroprotective Agent Historic Market Size by Country
8.1.1 Latin America Chondroprotective Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Chondroprotective Agent Sales in Volume by Country (2018-2024)
8.1.3 Latin America Chondroprotective Agent Sales in Value by Country (2018-2024)
8.2 Latin America Chondroprotective Agent Forecasted Market Size by Country
8.2.1 Latin America Chondroprotective Agent Sales in Volume by Country (2024-2029)
8.2.2 Latin America Chondroprotective Agent Sales in Value by Country (2024-2029)
9 Middle East and Africa Chondroprotective Agent by Country
9.1 Middle East and Africa Chondroprotective Agent Historic Market Size by Country
9.1.1 Middle East and Africa Chondroprotective Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Chondroprotective Agent Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Chondroprotective Agent Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Chondroprotective Agent Forecasted Market Size by Country
9.2.1 Middle East and Africa Chondroprotective Agent Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Chondroprotective Agent Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 SANXIN
10.1.1 SANXIN Company Information
10.1.2 SANXIN Introduction and Business Overview
10.1.3 SANXIN Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.1.4 SANXIN Chondroprotective Agent Products Offered
10.1.5 SANXIN Recent Development
10.2 WanTuMing Biological
10.2.1 WanTuMing Biological Company Information
10.2.2 WanTuMing Biological Introduction and Business Overview
10.2.3 WanTuMing Biological Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.2.4 WanTuMing Biological Chondroprotective Agent Products Offered
10.2.5 WanTuMing Biological Recent Development
10.3 TSI Group
10.3.1 TSI Group Company Information
10.3.2 TSI Group Introduction and Business Overview
10.3.3 TSI Group Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.3.4 TSI Group Chondroprotective Agent Products Offered
10.3.5 TSI Group Recent Development
10.4 Yantai Dongcheng
10.4.1 Yantai Dongcheng Company Information
10.4.2 Yantai Dongcheng Introduction and Business Overview
10.4.3 Yantai Dongcheng Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Yantai Dongcheng Chondroprotective Agent Products Offered
10.4.5 Yantai Dongcheng Recent Development
10.5 Focus Chem
10.5.1 Focus Chem Company Information
10.5.2 Focus Chem Introduction and Business Overview
10.5.3 Focus Chem Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Focus Chem Chondroprotective Agent Products Offered
10.5.5 Focus Chem Recent Development
10.6 YBCC
10.6.1 YBCC Company Information
10.6.2 YBCC Introduction and Business Overview
10.6.3 YBCC Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.6.4 YBCC Chondroprotective Agent Products Offered
10.6.5 YBCC Recent Development
10.7 Runxin Biotechnology
10.7.1 Runxin Biotechnology Company Information
10.7.2 Runxin Biotechnology Introduction and Business Overview
10.7.3 Runxin Biotechnology Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Runxin Biotechnology Chondroprotective Agent Products Offered
10.7.5 Runxin Biotechnology Recent Development
10.8 ISBA
10.8.1 ISBA Company Information
10.8.2 ISBA Introduction and Business Overview
10.8.3 ISBA Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.8.4 ISBA Chondroprotective Agent Products Offered
10.8.5 ISBA Recent Development
10.9 Huiwen
10.9.1 Huiwen Company Information
10.9.2 Huiwen Introduction and Business Overview
10.9.3 Huiwen Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Huiwen Chondroprotective Agent Products Offered
10.9.5 Huiwen Recent Development
10.10 QJBCHINA
10.10.1 QJBCHINA Company Information
10.10.2 QJBCHINA Introduction and Business Overview
10.10.3 QJBCHINA Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.10.4 QJBCHINA Chondroprotective Agent Products Offered
10.10.5 QJBCHINA Recent Development
10.11 Meitek (Synutra International)
10.11.1 Meitek (Synutra International) Company Information
10.11.2 Meitek (Synutra International) Introduction and Business Overview
10.11.3 Meitek (Synutra International) Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Meitek (Synutra International) Chondroprotective Agent Products Offered
10.11.5 Meitek (Synutra International) Recent Development
10.12 Hengjie Bio-Pharmaceuticals
10.12.1 Hengjie Bio-Pharmaceuticals Company Information
10.12.2 Hengjie Bio-Pharmaceuticals Introduction and Business Overview
10.12.3 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Products Offered
10.12.5 Hengjie Bio-Pharmaceuticals Recent Development
10.13 Nippon Zoki
10.13.1 Nippon Zoki Company Information
10.13.2 Nippon Zoki Introduction and Business Overview
10.13.3 Nippon Zoki Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Nippon Zoki Chondroprotective Agent Products Offered
10.13.5 Nippon Zoki Recent Development
10.14 GGI
10.14.1 GGI Company Information
10.14.2 GGI Introduction and Business Overview
10.14.3 GGI Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.14.4 GGI Chondroprotective Agent Products Offered
10.14.5 GGI Recent Development
10.15 Summit Nutritionals
10.15.1 Summit Nutritionals Company Information
10.15.2 Summit Nutritionals Introduction and Business Overview
10.15.3 Summit Nutritionals Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Summit Nutritionals Chondroprotective Agent Products Offered
10.15.5 Summit Nutritionals Recent Development
10.16 Sioux Pharm
10.16.1 Sioux Pharm Company Information
10.16.2 Sioux Pharm Introduction and Business Overview
10.16.3 Sioux Pharm Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sioux Pharm Chondroprotective Agent Products Offered
10.16.5 Sioux Pharm Recent Development
10.17 Ruikangda Biochemical
10.17.1 Ruikangda Biochemical Company Information
10.17.2 Ruikangda Biochemical Introduction and Business Overview
10.17.3 Ruikangda Biochemical Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Ruikangda Biochemical Chondroprotective Agent Products Offered
10.17.5 Ruikangda Biochemical Recent Development
10.18 Guanglong Biochem
10.18.1 Guanglong Biochem Company Information
10.18.2 Guanglong Biochem Introduction and Business Overview
10.18.3 Guanglong Biochem Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Guanglong Biochem Chondroprotective Agent Products Offered
10.18.5 Guanglong Biochem Recent Development
10.19 Pacific Rainbow
10.19.1 Pacific Rainbow Company Information
10.19.2 Pacific Rainbow Introduction and Business Overview
10.19.3 Pacific Rainbow Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Pacific Rainbow Chondroprotective Agent Products Offered
10.19.5 Pacific Rainbow Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chondroprotective Agent Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chondroprotective Agent Industrial Chain Analysis
11.4 Chondroprotective Agent Market Dynamics
11.4.1 Chondroprotective Agent Industry Trends
11.4.2 Chondroprotective Agent Market Drivers
11.4.3 Chondroprotective Agent Market Challenges
11.4.4 Chondroprotective Agent Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chondroprotective Agent Distributors
12.3 Chondroprotective Agent Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Sodium Hyaluronate
Table 2. Major Company of Glucosamine Sulfate
Table 3. Major Company of Chondroitin Sulfate
Table 4. Global Chondroprotective Agent Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Chondroprotective Agent Sales by Type (2018-2024) & (K Units)
Table 6. Global Chondroprotective Agent Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Chondroprotective Agent Sales by Type (2018-2024) & (US& Million)
Table 8. Global Chondroprotective Agent Market Share in Value by Type (2018-2024)
Table 9. Global Chondroprotective Agent Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Chondroprotective Agent Sales by Type (2024-2029) & (K Units)
Table 11. Global Chondroprotective Agent Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Chondroprotective Agent Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Chondroprotective Agent Sales Market Share in Value by Type (2024-2029)
Table 14. Global Chondroprotective Agent Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Chondroprotective Agent Sales by Type (2018-2024) & (K Units)
Table 16. North America Chondroprotective Agent Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Chondroprotective Agent Sales (K Units) by Type (2018-2024)
Table 18. Europe Chondroprotective Agent Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Chondroprotective Agent Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Chondroprotective Agent Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Chondroprotective Agent Sales (K Units) by Type (2018-2024)
Table 22. Latin America Chondroprotective Agent Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Chondroprotective Agent Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Chondroprotective Agent Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Chondroprotective Agent Sales by Company (2018-2024) & (K Units)
Table 26. Global Chondroprotective Agent Sales Share by Company (2018-2024)
Table 27. Global Chondroprotective Agent Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Chondroprotective Agent Revenue Share by Company (2018-2024)
Table 29. Global Market Chondroprotective Agent Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Chondroprotective Agent Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Chondroprotective Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chondroprotective Agent as of 2022)
Table 33. Date of Key Manufacturers Enter into Chondroprotective Agent Market
Table 34. Key Manufacturers Chondroprotective Agent Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Chondroprotective Agent Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Chondroprotective Agent Sales by Region (2018-2024) & (K Units)
Table 38. Global Chondroprotective Agent Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Chondroprotective Agent Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Chondroprotective Agent Sales Market Share in Value by Region (2018-2024)
Table 41. Global Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Chondroprotective Agent Sales by Region (2024-2029) & (K Units)
Table 43. Global Chondroprotective Agent Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Chondroprotective Agent Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Chondroprotective Agent Sales Market Share in Value by Region (2024-2029)
Table 46. Global Chondroprotective Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Chondroprotective Agent Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Chondroprotective Agent Sales by Application (2018-2024) & (K Units)
Table 49. Global Chondroprotective Agent Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Chondroprotective Agent Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Chondroprotective Agent Sales Market Share in Value by Application (2018-2024)
Table 52. Global Chondroprotective Agent Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Chondroprotective Agent Sales by Application (2024-2029) & (K Units)
Table 54. Global Chondroprotective Agent Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Chondroprotective Agent Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Chondroprotective Agent Sales Market Share in Value by Application (2024-2029)
Table 57. Global Chondroprotective Agent Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Chondroprotective Agent Sales by Application (2018-2024) (K Units)
Table 59. North America Chondroprotective Agent Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Chondroprotective Agent Sales by Application (2018-2024) (K Units)
Table 61. Europe Chondroprotective Agent Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Chondroprotective Agent Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Chondroprotective Agent Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Chondroprotective Agent Sales by Application (2018-2024) (K Units)
Table 65. Latin America Chondroprotective Agent Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Chondroprotective Agent Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Chondroprotective Agent Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Chondroprotective Agent Sales by Country (2018-2024) & (K Units)
Table 69. North America Chondroprotective Agent Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Chondroprotective Agent Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Chondroprotective Agent Sales Market Share in Value by Country (2018-2024)
Table 72. North America Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 73. North America Chondroprotective Agent Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Chondroprotective Agent Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Chondroprotective Agent Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Chondroprotective Agent Sales by Country (2018-2024) & (K Units)
Table 77. Europe Chondroprotective Agent Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Chondroprotective Agent Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Chondroprotective Agent Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 81. Europe Chondroprotective Agent Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Chondroprotective Agent Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Chondroprotective Agent Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Chondroprotective Agent Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Chondroprotective Agent Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Chondroprotective Agent Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Chondroprotective Agent Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Chondroprotective Agent Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Chondroprotective Agent Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Chondroprotective Agent Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Chondroprotective Agent Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Chondroprotective Agent Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Chondroprotective Agent Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Chondroprotective Agent Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Chondroprotective Agent Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Chondroprotective Agent Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Chondroprotective Agent Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Chondroprotective Agent Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Chondroprotective Agent Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Chondroprotective Agent Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Chondroprotective Agent Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Chondroprotective Agent Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Chondroprotective Agent Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Chondroprotective Agent Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Chondroprotective Agent Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Chondroprotective Agent Sales Market Share in Value by Country (2024-2029)
Table 108. SANXIN Company Information
Table 109. SANXIN Introduction and Business Overview
Table 110. SANXIN Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. SANXIN Chondroprotective Agent Product
Table 112. SANXIN Recent Development
Table 113. WanTuMing Biological Company Information
Table 114. WanTuMing Biological Introduction and Business Overview
Table 115. WanTuMing Biological Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. WanTuMing Biological Chondroprotective Agent Product
Table 117. WanTuMing Biological Recent Development
Table 118. TSI Group Company Information
Table 119. TSI Group Introduction and Business Overview
Table 120. TSI Group Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. TSI Group Chondroprotective Agent Product
Table 122. TSI Group Recent Development
Table 123. Yantai Dongcheng Company Information
Table 124. Yantai Dongcheng Introduction and Business Overview
Table 125. Yantai Dongcheng Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Yantai Dongcheng Chondroprotective Agent Product
Table 127. Yantai Dongcheng Recent Development
Table 128. Focus Chem Company Information
Table 129. Focus Chem Introduction and Business Overview
Table 130. Focus Chem Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Focus Chem Chondroprotective Agent Product
Table 132. Focus Chem Recent Development
Table 133. YBCC Company Information
Table 134. YBCC Introduction and Business Overview
Table 135. YBCC Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. YBCC Chondroprotective Agent Product
Table 137. YBCC Recent Development
Table 138. Runxin Biotechnology Company Information
Table 139. Runxin Biotechnology Introduction and Business Overview
Table 140. Runxin Biotechnology Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Runxin Biotechnology Chondroprotective Agent Product
Table 142. Runxin Biotechnology Recent Development
Table 143. ISBA Company Information
Table 144. ISBA Introduction and Business Overview
Table 145. ISBA Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. ISBA Chondroprotective Agent Product
Table 147. ISBA Recent Development
Table 148. Huiwen Company Information
Table 149. Huiwen Introduction and Business Overview
Table 150. Huiwen Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Huiwen Chondroprotective Agent Product
Table 152. Huiwen Recent Development
Table 153. QJBCHINA Company Information
Table 154. QJBCHINA Introduction and Business Overview
Table 155. QJBCHINA Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. QJBCHINA Chondroprotective Agent Product
Table 157. QJBCHINA Recent Development
Table 158. Meitek (Synutra International) Company Information
Table 159. Meitek (Synutra International) Introduction and Business Overview
Table 160. Meitek (Synutra International) Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Meitek (Synutra International) Chondroprotective Agent Product
Table 162. Meitek (Synutra International) Recent Development
Table 163. Hengjie Bio-Pharmaceuticals Company Information
Table 164. Hengjie Bio-Pharmaceuticals Introduction and Business Overview
Table 165. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product
Table 167. Hengjie Bio-Pharmaceuticals Recent Development
Table 168. Nippon Zoki Company Information
Table 169. Nippon Zoki Introduction and Business Overview
Table 170. Nippon Zoki Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Nippon Zoki Chondroprotective Agent Product
Table 172. Nippon Zoki Recent Development
Table 173. GGI Company Information
Table 174. GGI Introduction and Business Overview
Table 175. GGI Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. GGI Chondroprotective Agent Product
Table 177. GGI Recent Development
Table 178. Summit Nutritionals Company Information
Table 179. Summit Nutritionals Introduction and Business Overview
Table 180. Summit Nutritionals Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Summit Nutritionals Chondroprotective Agent Product
Table 182. Summit Nutritionals Recent Development
Table 183. Sioux Pharm Company Information
Table 184. Sioux Pharm Introduction and Business Overview
Table 185. Sioux Pharm Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Sioux Pharm Chondroprotective Agent Product
Table 187. Sioux Pharm Recent Development
Table 188. Ruikangda Biochemical Company Information
Table 189. Ruikangda Biochemical Introduction and Business Overview
Table 190. Ruikangda Biochemical Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Ruikangda Biochemical Chondroprotective Agent Product
Table 192. Ruikangda Biochemical Recent Development
Table 193. Guanglong Biochem Company Information
Table 194. Guanglong Biochem Introduction and Business Overview
Table 195. Guanglong Biochem Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. Guanglong Biochem Chondroprotective Agent Product
Table 197. Guanglong Biochem Recent Development
Table 198. Pacific Rainbow Company Information
Table 199. Pacific Rainbow Introduction and Business Overview
Table 200. Pacific Rainbow Chondroprotective Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 201. Pacific Rainbow Chondroprotective Agent Product
Table 202. Pacific Rainbow Recent Development
Table 203. Key Raw Materials Lists
Table 204. Raw Materials Key Suppliers Lists
Table 205. Chondroprotective Agent Market Trends
Table 206. Chondroprotective Agent Market Drivers
Table 207. Chondroprotective Agent Market Challenges
Table 208. Chondroprotective Agent Market Restraints
Table 209. Chondroprotective Agent Distributors List
Table 210. Chondroprotective Agent Downstream Customers
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Chondroprotective Agent Product Picture
Figure 2. Global Chondroprotective Agent Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Chondroprotective Agent Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Chondroprotective Agent Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Sodium Hyaluronate
Figure 6. Global Sodium Hyaluronate Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Glucosamine Sulfate
Figure 8. Global Glucosamine Sulfate Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Chondroitin Sulfate
Figure 10. Global Chondroitin Sulfate Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Chondroprotective Agent Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Chondroprotective Agent Sales Market Share by Type in 2022 & 2029
Figure 13. North America Chondroprotective Agent Sales Market Share in Volume by Type in 2022
Figure 14. North America Chondroprotective Agent Sales Market Share in Value by Type in 2022
Figure 15. Europe Chondroprotective Agent Sales Market Share in Volume by Type in 2022
Figure 16. Europe Chondroprotective Agent Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Chondroprotective Agent Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Chondroprotective Agent Sales Market Share in Value by Type in 2022
Figure 19. Latin America Chondroprotective Agent Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Chondroprotective Agent Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Chondroprotective Agent Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Chondroprotective Agent Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Chondroprotective Agent Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Chondroprotective Agent Revenue in 2022
Figure 25. Chondroprotective Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Ambulatory Surgery Center
Figure 29. Global Ambulatory Surgery Center Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Chondroprotective Agent Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Chondroprotective Agent Sales Market Share by Application in 2022 & 2029
Figure 32. North America Chondroprotective Agent Sales Market Share in Volume by Application in 2022
Figure 33. North America Chondroprotective Agent Sales Market Share in Value by Application in 2022
Figure 34. Europe Chondroprotective Agent Sales Market Share in Volume by Application in 2022
Figure 35. Europe Chondroprotective Agent Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Chondroprotective Agent Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Chondroprotective Agent Sales Market Share in Value by Application in 2022
Figure 38. Latin America Chondroprotective Agent Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Chondroprotective Agent Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Chondroprotective Agent Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Chondroprotective Agent Manufacturing Cost Structure
Figure 43. Chondroprotective Agent Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed